---
title: "AmoyDx: Shareholder Xiamen Keying has completed a reduction of 1.00% of its shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/240180570.md"
description: "AmoyDx announced that its shareholder Xiamen Keying Investment Partnership completed its reduction plan, selling 3.9252 million shares through block trades from April 23, 2025, to May 13, 2025, accounting for 1.00% of the total share capital. After the reduction, Xiamen Keying's shareholding ratio decreased to 4.06%"
datetime: "2025-05-14T13:07:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/240180570.md)
  - [en](https://longbridge.com/en/news/240180570.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/240180570.md)
generator: "portal-rs"
---

# AmoyDx: Shareholder Xiamen Keying has completed a reduction of 1.00% of its shares

AmoyDx announced that its shareholder, Xiamen Keying Investment Partnership, completed its reduction plan, selling 3.9252 million shares through block trading from April 23, 2025, to May 13, 2025, accounting for 1.00% of the total share capital. After the reduction, Xiamen Keying's shareholding ratio decreased to 4.06%

### Related Stocks

- [300685.CN](https://longbridge.com/en/quote/300685.CN.md)

## Related News & Research

- [Can Xiaomi Take On Porsche On Its Home Turf? It’s About To Try](https://longbridge.com/en/news/297946941.md)
- [Church's Texas Chicken's China debut drew 2-hour lines — and $22 offers to wait in them](https://longbridge.com/en/news/297600833.md)
- [LithiumBank shares trade on Germany’s Tradegate Exchange under symbol HT9](https://longbridge.com/en/news/297910536.md)
- [Fed ends enforcement action against United Texas Bank](https://longbridge.com/en/news/298057655.md)
- [Biohit says scientific review backs serum biomarker triage to target endoscopy for gastric cancer risk](https://longbridge.com/en/news/297887371.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**